Literature DB >> 16386567

Effects of dobutamine on right ventricular function and pulmonary circulation in pulmonary hypertension during liver transplantation.

F Acosta1, T Sansano, C G Palenciano, L Falcon, P Domenech, R Robles, F S Bueno, P Ramirez, P Parrilla.   

Abstract

INTRODUCTION: In the setting of orthotopic liver transplantation (OLT), pulmonary hypertension (PH) affects right ventricular (RV) function. When RV failure occurs, reducing RV afterload, optimizing RV preload, and preserving coronary perfusion through maintenance of systemic blood pressure are the primary goals of intraoperative treatment. PATIENTS AND METHODS: To verify the effect of dobutamine on RV function and RV-arterial coupling, we compared a group of 9 cirrhotic patients with mild PH treated with OLT to a group of 20 patients with normal mean pulmonary artery pressure (MPAP). All patients received dobutamine (5-10 microg/kg/min) to maintain a cardiac index (CI) >3 L/min/m(2), during the anhepatic phase. Hemodynamic profile, using a pulmonary artery catheter, was performed before and during dobutamine infusion, studying MPAP, CI, and RV end-diastolic volume index (RVEDVI). RV stroke work index (RVSWI), RV end-systolic elastance (Ees), pulmonary effective elastance (Ea), and RV-arterial coupling efficiency as the Ees/Ea ratio were also calculated.
RESULTS: RV contractility (Ees and RVSWI) and afterload (Ea) were significantly higher among the PH group. In both groups, all the studied variables improved with dobutamine: RV contractility increased, afterload decreased, and thus Ees/Ea coupling markedly increased.
CONCLUSION: Cirrhotic patients with mild PH who were undergoing OLT still have a reserve of RV contractile performance and pulmonary vasodilation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16386567     DOI: 10.1016/j.transproceed.2005.10.045

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  6 in total

Review 1.  Management of acute right ventricular failure in the intensive care unit.

Authors:  Corey E Ventetuolo; James R Klinger
Journal:  Ann Am Thorac Soc       Date:  2014-06

Review 2.  Pulmonary Hypertension.

Authors:  Peter Oishi; Jeffrey R Fineman
Journal:  Pediatr Crit Care Med       Date:  2016-08       Impact factor: 3.624

Review 3.  Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review.

Authors:  Laura C Price; Stephen J Wort; Simon J Finney; Philip S Marino; Stephen J Brett
Journal:  Crit Care       Date:  2010-09-21       Impact factor: 9.097

4.  Hepatopulmonary syndrome and portopulmonary hypertension.

Authors:  Adrian Hendrickse; Fareed Azam; M Susan Mandell
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-04

Review 5.  Pulmonary Hypertension in Intensive Care Units: An Updated Review.

Authors:  Armin Nowroozpoor; Majid Malekmohammad; Seyyed Reza Seyyedi; Seyed Mohammadreza Hashemian
Journal:  Tanaffos       Date:  2019-03

6.  Surviving 2019 novel coronavirus pneumonia: A successful critical case report.

Authors:  Lei Zou; Jiakui Sun; Ying Liu; Wenhao Zhang; Wei Jiang; Shoutao Yuan; Qiankun Shi
Journal:  Heart Lung       Date:  2020-08-20       Impact factor: 2.210

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.